Perched Holding

Perched (legally Perched Holding, LLC) is a stealth-mode biotechnology company founded by CRISPR pioneer Feng Zhang. The company is focused on developing a "programmable biology" platform, leveraging novel molecular tools and genetic engineering techniques to create next-generation therapeutics. While specific disease areas and drug candidates remain undisclosed, the company has secured over $100 million in funding from leading venture capital firms, including ARCH Venture Partners and Foresite Capital. Perched aims to build upon Zhang's foundational work at the Broad Institute to make biological systems as programmable as software. The startup represents a significant new entry in the field of genetic medicine and molecular discovery.